ThesaurusAntonymsRelated WordsSynonymsLegend:

Noun

thrombocytopenic purpura - purpura associated with a reduction in circulating blood platelets which can result from a variety of factors

idiopathic thrombocytopenic purpura, purpura hemorrhagica, Werlhof's disease

autoimmune disease, autoimmune disorder - any of a large group of diseases characterized by abnormal functioning of the immune system that causes your immune system to produce antibodies against your own tissues

peliosis, purpura - any of several blood diseases causing subcutaneous bleeding

Mentioned in

References in periodicals archive

In the U.S., idiopathic thrombocytopenic purpura (ITP) impacts the lives of 4-8per 100,000 children under the age of 15 each year in the U.S.

Purpura Treatment Market Analysis 2019 Global Industry Forecast To 2022: By Size, Growth, Trends, Share, Competitive Landscape and Regional Outlook

Over the next 12-15 months, we anticipate key readouts from our clinical candidates, including top-line data in 2020 from our Phase 2 studies of nipocalimab in generalized myasthenia gravis and M254 in Immune Thrombocytopenic Purpura."

Momenta reports Q2 EPS ($1.16), consensus (42c)

Primary thrombocytopenic purpura and acquired hemolytic anemia; evidence for a common etiology.

Evans Syndrome and pregnancy: A case report with literature review

It was launched for the treatment of idiopathic thrombocytopenic purpura (ITP) and has contributed to many ITP patients since April 2011.

Kyowa Hakko Kirin Receives the Partial Change Approval of Romiplate for Aplastic Anemia in Japan

Immune thrombocytopenic purpura (ITP) is a syndrome that reduces platelet levels, and it is caused by the development of autoantibodies against thrombocytes.

Emergency Surgical Intervention to Treat a Wide Septated Subdural Hematoma in a Patient with ITP: A Case Report

M2 EQUITYBITES-February 7, 2019-Sanofi wins US FDA approval for Cablivi for treating acquired thrombotic thrombocytopenic purpura

Sanofi wins US FDA approval for Cablivi for treating acquired thrombotic thrombocytopenic purpura

Global Banking News-February 7, 2019-Sanofi wins US FDA approval for Cablivi for treating acquired thrombotic thrombocytopenic purpura

Sanofi wins US FDA approval for Cablivi for treating acquired thrombotic thrombocytopenic purpura

M2 PHARMA-February 7, 2019-Sanofi wins US FDA approval for Cablivi for treating acquired thrombotic thrombocytopenic purpura

Sanofi wins US FDA approval for Cablivi for treating acquired thrombotic thrombocytopenic purpura

Thrombotic thrombocytopenic purpura (TTP) is characterized by microangiopathic hemolytic anemia, thrombocytopenia, and organ dysfunction.

Vincristine as an Adjunct to Therapeutic Plasma Exchange for Thrombotic Thrombocytopenic Purpura: A Single-Institution Experience

The record of 103 patients was reviewed retrospectively during the study period, diagnosed as acute Idiopathic Thrombocytopenic Purpura. The median age, at the time of presentation, was 5+-3.4 years while mean age was 4.5+-2.9 years.

Clinical features and outcome in paediatric newly diagnosed immune thrombocytopenic purpura in a tertiary care centre

Objective: To assess clinical presentation and outcome of patients with thrombotic thrombocytopenic purpura (TTP) in our setup.

THROMBOTIC THROMBOCYTOPENIC PURPURA: OUR CLINICAL EXPERIENCE